Home > Drug Search >
  • company_query: Biocon
  •   > 
Drug Filter
Category:
chemistry (4) biology (34)
Status:
Approved (8) BLA Filing (2) Phase Ⅲ (7) Phase Ⅱ (18) Phase Ⅰ (3)
Clinical Stage:
Pending (2) Active (25) Discontinued (3)
Bio-Type:
Coagulation factor (1) Gene therapy (2) Cell therapy (1) Vaccine (2) Recombinant enzyme (1) Recombinant cytokines (6) Recombinant hormone (1) Whole antibody (9) Fusion protein (1)
Indication:
Non-alcoholic steatohepatitis (1) Acute myeloid Leukemia (AML) (1) Amyotrophic lateral sclerosis (ALS) (1) Anaesthetic (1) Anemia (2) Breast cancer (2) Chronic lymphocytic leukemia (CLL) (1) Cystic fibrosis (CF) (1) Neuronal ceroid lipofuscinoses (1) Deep vein thrombosis (DVT) (1) Diabetic macular edema (1) Follicular lymphoma (2) HBV infection (1) HCV infection (2) Alcoholic hepatitis (1) Hepatocellular carcinoma (HCC) (1) HIV infection (1) Ischaemia (1) Inflammatory bowel disease (1) Pseudomonal infection (1) Graves ophthalmopathy (1) Melanoma (1) Multiple myeloma (MM) (2) Myeloid leukemia (1) Myocardial infarction (MI) (1) Non-Hodgkin’s lymphoma (NHL) (2) Pancreatic cancer (2) Pneumonia (1) Prostate cancer (2) Pulmonary embolism (1) Rheumatoid arthritis (RA) (2) Solid tumours (2) Type 2 diabetes (1) Colorectal cancer (3) Nosocomial Pneumonia (NP) (1) Paroxysmal Nocturnal Hemoglobinuria (PNH) (1) Autistic disorder (1) Type 1 diabetes (1) Neutropenia (4) Renal carcinoma (2) Autoimmune diseases (1) venous stasis ulcers (1) Glioma (2) Plaque psoriasis (3) Bleeding (1) Diffuse large B cell lymphoma (2) Central nervous system disorders (1) Skin disorders (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top